Lv1
30 积分 2025-11-11 加入
High-Throughput Screening of an FDA-Approved Compound Library Reveals a Novel GAS6 Receptor Agonist for Therapeutic Intervention in Septic Myocardial and microvascular Injury via Modulation of Danger-Associated Molecular Patterns
39分钟前
待确认
Effects of Xuebijing combined with levosimendan on immune function and coagulation function in sepsis patients with myocardial injury
9天前
已完结
皖公网安备34019202002308
